Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues

Journal of Medical Virology

Volumn 79, Issue 11, 2007, Pages 1671-1673

  Rodriguez Frias, Francisco ^a,b   Jardi, Rosendo ^a,b   Schaper, Melanie ^a,b   Gimferrer, Montserrat ^a   Elefsiniotis, Ioannis ^a   Tabernero, David ^b   Esteban, Rafael ^a,b   Buti, Maria ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Chronic hepatitis B; Drug resistance; Entecavir; Hepatitis B virus; Lamivudine; Therapy

Indexed keywords

ADEFOVIR DIPIVOXIL; ENTECAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENOTYPE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; MALE; MONOTHERAPY; VIRUS DETECTION;

ADENINE; ADULT; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, VIRAL; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MUTATION; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS;

HEPATITIS B VIRUS;

EID: 34748925265     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20982     Document Type: Article

References (11)

1. Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, Lok AS, Han KH, Goodman Z, Zhu J, Cross A, DeHertogh D, Wilber R, Colonno R, Apelian D. BEHoLD AI463022 Study Group. 2006. A comparison of entecavir and lamivudine for HBeAg positive chronic hepatitis B. N Engl J Med 354:1001-1010.
2. Colonno RJ, Rose R, Levine SM, Pokornowski K, Plym M, Yu CF, Baidick CJ, Zhang S, Walsh AW, Discotto L, Fang J, Tenney DJ. Emergence of entecavir-resistant hepatitis B virus after one year of therapy in phase II and III studies is only observed in lamivudine refractory patients 55th Annual Meeting of the American Association for the Study of Liver Diseases. October 29-November 2 2004 Boston, MA, USA Abstract 661A.
3. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Valdes A, Galimany R, Esteban R, Guardia J. 2001. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepat 8:465-471.
4. Lai ChL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross R, Ferenandez L. BEHoLD AI463027 Study Group. 2006. Entecavir versus lamivudine for patients HBeAg negative chronic hepatitis B. N Engl J Med 354:1011-1020.
5. Lampertico P, Vigano M, Manenti E, Iavarone M, Lunghi G, Colombo M. 2005. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatologt 42:1414-1419.
6. Levine S, Hernández D, Yamanaka G, Zhang S, Rose R, Weinheimer S, Colonno RJ. 2002. Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro. Antimicrob Agents Chemother 46:2525-2532.
7. Rodriguez-Frias F, Buti M, Jardi R, Cotrina M, Viladomiu L, Esteban R, Guardia J. 1995. Hepatitis B virus infection. Precore mutants and its relation to viral genotypes. Hepatology 22:1461-1467.
8. Shermann M, Yurdaydin C, Sollano J, Silva M, Liaw YF, Cianciara J, Boron-Kaczmarska A, Martin P, Goodman Z, Colonno R, Cross A, Denisky G, Kreter B, Hindes R. AI463026 BEHoLD Study Group. 2006. Entecavir for treatment of lamivudine refractory HBeAg positive chronic hepatitis B. Gastroenterology 130:2039-2049.
9. Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Plym M, Pokornowski K, Yu CF, Angus P, Ayres A, Bartholomeusz A, Sievert W, Thompson G, Warner N, Locarnini S, Colonno RJ. 2004. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob Agents Chemother 48:3507-3548.
10. Yang H, Qi X, Sabogal A, Miller M, Xiong S, Delaney W. 2005. Cross-resistance testing of next generation nucleoside and nucleotide analogues against lamivudine-resistant HBV. Antivir Ther 10:625-633.
11. Zoulim F. 2006. Entecavir: A new treatment option for chronic hepatitis B. J Clin Virol 36:8-12.